Highest-materiality recent filing
McKesson discloses cybersecurity incident on Aug 25, 2026; investigation early
Cybersecurity incident discovered Aug 25, 2026 affecting information systems; investigation in early stages.
McKesson Q1 adjusted EPS $9.93 (+20% YoY); raises FY2027 guidance to $44.20-$45.00
Revenue $105.4B (+8% YoY); GAAP EPS $5.15 (down $1.10); adjusted EPS $9.93 (+20%).
All 11 director nominees elected; Brian S. Tyler received 86.8M for, 7.8M against; Maria N. Martinez received 88.5M for, 6.0M against.
McKesson EVP & Chief Strategy Officer Thomas Rodgers to retire; Ramesh Srinivasan named successor
Thomas L. Rodgers, EVP, Chief Strategy and Business Development Officer, retires effective Aug 1, 2026.
McKesson subsidiary adds $2.25B senior secured term loan facility due 2032
Amendment to April 1, 2026 Credit Agreement creates $2.25B Term B Loan Facility maturing 2032.
McKesson Q4 adj EPS $11.69 (+16% YoY); FY2027 guidance $43.80-$44.60
Q4 revenue $96.3B (+6%), full-year $403.4B (+12%); GAAP EPS $13.71, adjusted EPS $39.11 (+18% FY).
McKesson enters $5B revolving credit facility maturing April 2031
New $5.0B revolving credit facility replaces $1.0B 364-day and $4.0B five-year facilities.
McKesson unit enters $2B senior secured credit facility with term loans and revolver
$750M term loan A-1 due 2031, $250M term loan A-2 due 2028, and $1B revolver due 2031.
McKesson reaffirms FY2026 outlook, sets Q4 earnings release for May 7, 2026
Q4 fiscal 2026 earnings to be released after market close on May 7, 2026; webcast at 4:30 PM ET.
McKesson CFO Britt Vitalone to retire; Kenny Cheung named successor effective May 29, 2026
Britt Vitalone retires as CFO effective May 28, 2026; will advise as contractor from July 2 at $50K/month.
McKesson Q3 revenue $106.2B +11%, adj EPS $9.34 +16%, raises FY guidance
GAAP EPS $9.59 vs $6.95 YoY; adjusted EPS $9.34 vs $8.03, up 16%.
McKesson Q2 adjusted EPS $9.86, +39% YoY; revenue record $103.2B; raises FY26 guidance
Quarterly revenue $103.2B (+10% YoY); GAAP EPS $8.92 vs $1.87; adjusted EPS $9.86 vs $7.07 (+39%).
Fiscal 2026 Adjusted EPS guidance raised and narrowed to $38.05-$38.55 from $37.10-$37.90.
McKesson reorganizes into 4 segments; restates FY2025 revenue of $359B under new structure
Starting Q2 FY2026, McKesson will report 4 segments: North American Pharmaceutical, Oncology & Multispecialty, Prescription Technology Solutions, Medical-Surgical Solutions.
Consolidated revenue $97.8B, up 23% YoY; GAAP diluted EPS $6.25 (down $0.75); Adjusted EPS $8.26 (up 5%).
McKesson shareholders elect all 12 director nominees; ratify auditor; approve say-on-pay
All 12 board nominees elected; Maria N. Martinez received most votes against (6.1M of ~100M cast).
McKesson raises FY2026 adjusted EPS guidance to $36.90-$37.70 from $36.75-$37.55
Adjusted EPS guide increased by $0.15 at midpoint to $36.90-$37.70.
McKesson issues $2B notes to fund acquisition of 70% stake in Community Oncology Revitalization
Issued $650M 4.650% notes due 2030, $650M 4.950% notes due 2032, $700M 5.250% notes due 2035.
Q4 consolidated revenues $90.8B (+19% YoY); GAAP diluted EPS $10.01; adjusted diluted EPS $10.12 (+64%).
McKesson Q3 FY25 revenue $95.3B (+18%); raises adjusted EPS guidance to $32.55-$32.95
Q3 FY25 revenue $95.3B (+18% YoY); GAAP EPS $6.95 (+57%); adjusted EPS $8.03 (+4%).
GAAP diluted EPS $6.95 vs $4.42 prior year; adjusted EPS $8.03 vs $7.74 (+4%).
McKesson Q2 FY2025 revenue $93.7B (+21%), adj. EPS $7.07 (+13%), raises FY25 adj. EPS guidance
Revenue $93.7B, +21% YoY; GAAP diluted EPS $1.87 (down 62% vs $4.92); adjusted EPS $7.07 (+13%).
McKesson issues $500M 4.250% notes due 2029 to redeem higher-rate 2026 notes
Issued $500M aggregate principal of 4.250% Notes due 2029 at 99.946% of par.
McKesson reaffirms FY2025 adj. EPS $31.75-$32.55, Q2 range $6.70-$7.00
Reaffirmed fiscal 2025 full-year adjusted EPS guidance $31.75-$32.55.
McKesson signs deal to buy 70% of Core Ventures (FCS) for ~$2.49B cash
Purchase price approx. $2.49B in cash for ~70% controlling equity interest in Core Ventures (FCS's admin services org).
McKesson Q1 adjusted EPS $7.88 (+8% YoY); raises FY2025 guidance, boosts dividend 15%
Revenues $79.3B (+6% YoY); net income $915M (-4%); GAAP EPS $7.00 flat.
McKesson shareholders elect all 11 directors, ratify auditor at 2024 annual meeting
All 11 board nominees elected by majority; Brian S. Tyler received 103.4M for, 0.8M against.
McKesson elects Deborah Dunsire to board; two directors to step down at 2024 annual meeting
Deborah Dunsire, former CEO of H. Lundbeck, elected to McKesson board effective June 3, 2024; will serve on Compensation/Talent and Finance committees.
McKesson Q4 revenue +11% but adjusted EPS -14%; FY2025 guidance 14-17% growth
Q4 revenue $76.4B (+11% YoY); full-year revenue $309B (+12% YoY).
McKesson FQ3 revenue $80.9B (+15% YoY), adjusted EPS $7.74 (+12%), raises FY guidance
Revenue $80.9B up 15% YoY; GAAP EPS from continuing ops $4.42 vs $7.65 (down 42%).
McKesson acquires healthcare data platform Compile; adds Kevin Ozan to board
Kevin Ozan elected to McKesson board, effective Jan 8, 2024; board expands to 12 members.
McKesson extends revolving credit facility maturity to November 2028
Maturity of revolving credit facility extended from Nov 7, 2027 to Nov 7, 2028, all other terms unchanged.
McKesson Q2 revenue $77.2B (+10%), adj EPS $6.23; raises FY24 guidance; CLO succession
Total revenues $77.2B, up 10% YoY; income from continuing ops $664M (-29%).
Reaffirms FY2024 Adjusted EPS guidance issued August 2, 2023, despite Rite Aid's Chapter 11 filing on October 15.
CFO Britt Vitalone adds Tech & M&A oversight; Fraga appointed CIO/CTO; Avila steps down
EVP & CFO Britt Vitalone adds responsibilities for Technology Organization and M&A, effective Oct 3, 2023.
McKesson Q1 FY2024 revenues $74.5B (+11%); adj EPS $7.27 (+25%); raises FY guidance
Revenues $74.5B, up 11% YoY; income from cont ops $958M (+25%).
All 11 director nominees elected with majority votes; no nominee received less than 103.4M for votes.
McKesson issues $1B of 4.900%/5.100% notes due 2028/2033; retires $271M of 2024 notes via tender
Issued $400M 4.900% notes due 2028 and $600M 5.100% notes due 2033; net proceeds ~$991.2M after underwriting.
McKesson commences tender offer for any and all $918M of 3.796% Notes due 2024
Tender offer for any and all $918,070,000 of 3.796% Notes due 2024; expires June 13, 2023.
McKesson Q4 adjusted EPS $7.19 (+23% YoY); FY2024 guidance $26.10-$26.90
Q4 revenues $68.9B (+4% YoY); full-year revenues $276.7B (+5%).
McKesson board adopts bylaw amendments tightening stockholder proposal and nomination rules
Stockholders must maintain ownership through meeting date; special meeting requests require record-date holder status and compliance with Rule 14a-19.
McKesson issues $500M of 5.250% Notes due 2026; net proceeds ~$497.8M
$500M aggregate principal; 5.250% interest; matures 2026; interest payable Feb 15 and Aug 15.
McKesson Q3 FY23: EPS $7.65, adj. EPS $6.90; raises full-year guidance to $25.75-$26.15
Total revenues $70.5B (+3%); GAAP diluted EPS $7.65 vs. ($0.04) YoY.
McKesson enters new $4B revolver maturing 2027 and $500M term loan maturing 2025
$4.0B revolving credit facility matures Nov 2027, replaces $4.0B facility set to mature Sep 2024.
McKesson Q2 revenue $70.2B (+5%), EPS $6.46 vs $1.71; raises FY23 adj. EPS guidance to $24.45-24.95
Total revenues of $70.2B increased 5% YoY; income from continuing operations $932M vs $267M.
McKesson names LeAnn B. Smith as new CHRO; Tracy L. Faber to retire Dec 1, 2022
Tracy L. Faber, EVP and CHRO, retires after 11-year tenure at McKesson.
McKesson Q1 adj EPS $5.83, revenue $67.2B; raises FY2023 outlook to $23.95-$24.65
Adjusted EPS $5.83 vs $5.56 (+5%); GAAP EPS $5.25 vs $3.09 (+70%).
McKesson shareholders re-elect directors, approve plans; shareholder proposals rejected
All 11 director nominees elected with majority support; no close contests.
McKesson Q4 revenue $66.1B (+12%), adj EPS $5.83 (+15%); FY2023 adj EPS guide $22.90-$23.60
Q4 revenues $66.1B (+12% YoY); diluted EPS from cont ops $2.48 (vs $4.15 prior year).
McKesson adopts revised Executive Severance Policy and amends incentive plans
Executive Severance Policy provides up to 24 months' base salary on Qualifying Termination (lesser of 12 months + 1 month per service year or 24 months).
Linda Mantia and Susan R. Salka will not be standing for re-election at the Corporation’s 2024 annual meeting of shareholders (“Annual Meeting”), and their terms will expire effective at the Annual Meeting.
On May 31, 2024, the Board of Directors (“Board”) of McKesson Corporation (“Corporation”) elected Deborah Dunsire, M.D. as a director of the Corporation and appointed her to the Board’s Compensation and Talent Committee and Finance Committee, effective June 3, 2024.
Linda Mantia and Susan R. Salka will not be standing for re-election at the Corporation’s 2024 annual meeting of shareholders (“Annual Meeting”), and their terms will expire effective at the Annual Meeting.
On January 8, 2024, the Board of Directors (“Board”) of McKesson Corporation (“Corporation”) elected Kevin Ozan as a director of the Corporation and appointed him to the Board’s Audit Committee and Finance Committee, effective January 8, 2024.
On October 27, 2023, Lori A. Schechter, the Company’s Chief Legal Officer, gave notice of her intention to retire from that role as further described in Exhibit 99.1 under the heading Executive Leadership Transition.
Nancy Avila, Executive Vice President, Chief Information Officer and Chief Technology Officer stepped down from her role and as an executive officer of the Company effective October 2, 2023.
On September 7, 2022, Tracy L. Faber, Executive Vice President and Chief Human Resources Officer, who is a named executive officer of McKesson Corporation (“Company”), gave the Company notice of her decision to retire from the Company effective on December 1, 2022.
On March 31, 2022, the Board of Directors (“Board”) of McKesson Corporation (“Company”) elected W. Roy Dunbar as a director of the Corporation, and appointed him to the Audit Committee and Governance Committee, effective on April 1, 2022.
On February 21, 2022, Napoleon B. Rutledge, Jr., 49, was appointed as Senior Vice President, Controller and Chief Accounting Officer of McKesson Corporation
In connection with Mr. Rutledge's appointment, Kevin W. Emerson will be leaving his interim positions as the Company's Controller and Chief Accounting Officer.
On January 13, 2022, the Board of Directors (“Board”) of McKesson Corporation (“Company”) elected James H. Hinton and Kathleen Wilson-Thompson as directors of the Corporation effective on January 13, 2022.
On January 13, 2022, the Board of Directors (“Board”) of McKesson Corporation (“Company”) elected James H. Hinton and Kathleen Wilson-Thompson as directors of the Corporation effective on January 13, 2022.
Max materiality 0.90 · Median 0.60 · Most common event earnings